Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

Risk-factor modification to prevent recurrent atrial fibrillation after catheter ablation

Jack Hartnett, MB, BCh, BAO, MSc, Nour Chouman, MD and Eoin Donnellan, MD
Cleveland Clinic Journal of Medicine January 2025, 92 (1) 53-61; DOI: https://doi.org/10.3949/ccjm.92a.24011
Jack Hartnett
Department of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Nour Chouman
Tulane Research Innovation for Arrhythmia Discovery, Tulane University School of Medicine, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eoin Donnellan
Tulane Research Innovation for Arrhythmia Discovery, Tulane University School of Medicine, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    Risk factors for atrial fibrillation

    Hypertension
    Diabetes mellitus
    Dyslipidemia
    Obesity
    Obstructive sleep apnea
    Metabolic dysfunction–associated steatotic liver disease
    Smoking
    Alcohol consumption
    Physical inactivity
    • View popup
    TABLE 2

    Summary of evidence surrounding preablation and postablation risk-factor modification

    Risk factorBefore the procedureAfter the procedure
    HypertensionHypertension increases incidence of atrial fibrillation5
    Periprocedural renal denervation reduces blood pressure and atrial fibrillation recurrence12
    Whether aggressive hypertension management before ablation provides additional benefit in preventing atrial fibrillation recurrences is unclear11
    Hypertension increases postprocedural atrial fibrillation recurrence risk8
    Rates of recurrence in patients with controlled hypertension are similar to those of patients with no hypertension9
    Diabetes mellitusDiabetes mellitus increases incidence of atrial fibrillation15
    Periprocedural role of sodium-glucose cotransporter 2 inhibitors is unclear
    Hemoglobin A1c control reduces atrial fibrillation recurrence18
    ObesityObesity increases both incidence and severity of atrial fibrillation29,30
    Preprocedural weight management, including bariatric surgery, improves success33–35,38
    Obstructive sleep apneaContinuous positive airway pressure reduces atrial fibrillation recurrence in patients with obstructive sleep apnea43,44
    Metabolic dysfunction–associated steatotic liver diseasePreprocedural management is beneficial46
    Role of pharmacotherapy is unclear
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 92 (1)
Cleveland Clinic Journal of Medicine
Vol. 92, Issue 1
1 Jan 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk-factor modification to prevent recurrent atrial fibrillation after catheter ablation
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Risk-factor modification to prevent recurrent atrial fibrillation after catheter ablation
Jack Hartnett, Nour Chouman, Eoin Donnellan
Cleveland Clinic Journal of Medicine Jan 2025, 92 (1) 53-61; DOI: 10.3949/ccjm.92a.24011

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Risk-factor modification to prevent recurrent atrial fibrillation after catheter ablation
Jack Hartnett, Nour Chouman, Eoin Donnellan
Cleveland Clinic Journal of Medicine Jan 2025, 92 (1) 53-61; DOI: 10.3949/ccjm.92a.24011
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • SCOPE OF THE PROBLEM
    • HYPERTENSION: MIXED EVIDENCE, BUT USUAL GUIDELINES APPLY
    • DIABETES MELLITUS: USUAL GUIDELINES ALSO APPLY
    • DYSLIPIDEMIA: NO EVIDENT BENEFIT FROM TREATMENT
    • OBESITY: WEIGHT LOSS RECOMMENDED
    • OBSTRUCTIVE SLEEP APNEA: CPAP ENCOURAGED
    • METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE
    • SMOKING AND ALCOHOL CONSUMPTION: QUITTING IS RECOMMENDED
    • PHYSICAL INACTIVITY
    • COMPLETE RISK-FACTOR MODIFICATION
    • AGGRESSIVE OPTIMIZATION IS THE FUTURE
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Alpha-gal syndrome: Recognizing and managing a tick-bite–related meat allergy
  • Managing right ventricular failure in the setting of pulmonary embolism
  • Psychedelics, spirituality, and existential distress in patients at the end of life
Show more Review

Similar Articles

Subjects

  • Cardiology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire